June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Agonist activity and binding affinity of ONO-9054 to EP3 and FP Receptors
Author Affiliations & Notes
  • Shinsaku Yamane
    ONO PHARMACEUTICAL CO.,LTD., Osaka, Japan
  • Satoshi Nakayama
    ONO PHARMACEUTICAL CO.,LTD., Osaka, Japan
  • Tomohiro Karakawa
    ONO PHARMACEUTICAL CO.,LTD., Osaka, Japan
  • Shintaro Nakao
    ONO PHARMACEUTICAL CO.,LTD., Osaka, Japan
  • Tsutomu Shiroya
    ONO PHARMACEUTICAL CO.,LTD., Osaka, Japan
  • Yutaka Shichino
    ONO PHARMACEUTICAL CO.,LTD., Osaka, Japan
  • Footnotes
    Commercial Relationships Shinsaku Yamane, ONO PHARMACEUTICAL CO., LTD. (E); Satoshi Nakayama, ONO Pharmaceutical Co Ltd (E); Tomohiro Karakawa, ONO PHARMACETICAL CO., LTD (E); Shintaro Nakao, ONO Pharmaceutical Co.,LTD (E); Tsutomu Shiroya, ONO Pharmaceutical.Co.Ltd. (E); Yutaka Shichino, ONO Pharmaceutical Co Ltd (E)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 766. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shinsaku Yamane, Satoshi Nakayama, Tomohiro Karakawa, Shintaro Nakao, Tsutomu Shiroya, Yutaka Shichino; Agonist activity and binding affinity of ONO-9054 to EP3 and FP Receptors. Invest. Ophthalmol. Vis. Sci. 2013;54(15):766.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: ONO-9054 (Ono Pharmaceuticals, Osaka Japan) is a novel prodrug compound. ONO-9054 is an isopropyl ester derivative of the free acid ONO-AG-367. The purpose of this study was to investigate the agonist activity and binding affinity of ONO-9054 and ONO-AG-367 to the prostaglandin receptors. To investigate the potential off-target effects of ONO-9054 and ONO-AG-367, the binding affinity for 66 receptors and transporters were studied.

Methods: The binding affinity of ONO-9054 and ONO-AG-367 to prostaglandin receptors (EP1, EP2, EP3, EP4, FP, IP, TP, and DP receptors) was assessed with cells over expressing each prostaglandin receptor. The agonist activities of ONO-9054 and ONO-AG-367 were examined using the intracellular calcium signaling response in EP3 or FP receptor-expressing cells. The binding affinity of ONO-9054 and ONO-AG-367 on 66 additional receptors and transporters were also assessed.

Results: ONO-9054 exhibited high affinity for the FP receptor only and no affinity for any other prostaglandin receptors. ONO-AG-367 exhibited high affinity for both the EP3 and FP receptors. ONO-AG-367 exhibited potent agonist activity with EC50 values of 14.8 nmol/L for the EP3 receptor and 11.1 nmol/L for the FP receptor, respectively. ONO-9054 exhibited a low potency agonist effect on these receptors. ONO-9054 and ONO-AG-367 at 10 μmol/L did not produce greater than 35% inhibition of binding at any of the 66 other targets examined.

Conclusions: ONO-AG-367, the biologically active free acid of ONO-9054, is a highly selective and potent prostaglandin FP and EP3 receptor agonist. The agonist activity of ONO-AG-367 to FP receptor was similar to previously reported values of FP agonists such as latanoprost acid, bimatoprost acid, and travoprost acid. On the other hand, the agonist activity of ONO-AG-367 to EP3 receptor was more potent than these FP agonists.

Keywords: 675 receptors: pharmacology/physiology  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×